AMR SVG Icons location

Managing Trace Elements in Parenteral Nutrition

A new website providing educational content and treatment guidelines

Explore Now

Dedicated to Alleviating Drug Shortages

We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients.

Learn more

Check Product Availability

Updated September 23, 2023

View All
HydrALAZINE Hydrochloride Vial Image

HydrALAZINE Hydrochloride

  • 20 mg/mL | 1 mL Single Dose Vial
  • Shelf Pack — 25
Papaverine HCL Vial Image

Papaverine HCL

  • 30 mg/mL | 2 mL Single Dose Vial
  • Shelf Pack — 25
Zinc Sulfate Vial Image

Zinc Sulfate

  • 5 mg/mL | 5 mL Pharmacy Bulk Package Vial
  • Shelf Pack — 25

News Center

American Regent Announces Results from Phase 3 HEART-FID Trial with INJECTAFER®

Shirley, NY–August 26, 2023: American Regent, Inc., a Daiichi Sankyo Group company, today announced results from the phase 3 HEART-FID trial of INJECTAFER (ferric carboxymaltose injection) for the treatment of iron deficiency in adult heart failure patients with reduced ejection fraction (HFrEF).

INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure

Basking Ridge, NJ and Shirley, NY – June 5, 2023: Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER® (ferric carboxymaltose injection) for the treatment of iron deficiency in adult patients with heart failure categorized as New York Heart Association class II/III to improve exercise capacity.

St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship Now Recruiting

Melville, NY – September 14, 2023:
Learn more about the St. John’s University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship by downloading our brochure. Information on how to apply to our program as well as key deadlines are included.

Contact Us

Request for Medical Information Request a Grant Investigator Initiated Study Request a Certificate of Analysis Expanded Access Policy
Please choose your preferred method of contact

By clicking Submit, you confirm that you accept our Privacy Policy and that you agree to your personal contact information being used to contact you and added to our database. If at any time you wish your personal information to be removed from the American Regent® database, please submit a message request to corpcommunications@americanregent.com.